Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm
Go back to Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm| StemCells, Inc. (NASDAQ: TEM) | Delayed: 64.62 -0.04 (0.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.66 | 52 Week High | $0.45 | |||
| Open | $64.76 | 52 Week Low | $0.37 | |||
| Day High | $66.30 | P/E | N/A | |||
| Day Low | $63.11 | EPS | $-0.31 | |||
| Volume | 4,574,993 | |||||

